Laflunimus, CAS 147076-36-6

Laflunimus, CAS 147076-36-6
SKU
MEXHY-101813-25
Packaging Unit
25 mg
Manufacturer
MedChemExpress

Availability: loading...
Price is loading...
Product Description: Laflunimus (HR325) is an immunosuppressive agent and an analogue of the Leflunomide-active metabolite A77 1726. Laflunimus is an orally active inhibitor of dihydroorotate dehydrogenase (DHODH). Laflunimus suppresses immunoglobulin (Ig) secretion, with IC50 values of 2.5 and 2 μM for IgM and IgG, respectively. Laflunimus also is a prostaglandin endoperoxide H synthase (PGHS) -1 and -2 inhibitor[1][2].

Applications: COVID-19-anti-virus

Formula: C15H13F3N2O2

References: [1]Thomson TA, et al. In vitro and in Vivo inhibition of immunoglobulin secretion by the immunosuppressive compound HR325 is reversed by exogenous uridine. Scand J Immunol. 2002 Jul;56(1):35-42./[2]Curnock AP, et al. Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 1997 Jul;282(1):339-47.

CAS Number: 147076-36-6

Molecular Weight: 310.27

Compound Purity: 99.76

Research Area: Inflammation/Immunology

Solubility: DMSO : 50 mg/mL (ultrasonic)

Target: Dihydroorotate Dehydrogenase;DNA/RNA Synthesis;Prostaglandin Receptor
More Information
SKU MEXHY-101813-25
Manufacturer MedChemExpress
Manufacturer SKU HY-101813-25
Package Unit 25 mg
Quantity Unit STK
Product information (PDF)
×
MSDS (PDF)
×